Medera and Singapore’s Cardiovascular Disease National Collaborative Enterprise Launch Asia's First Cardiac Gene Therapy ...
Medera and Cardiovascular Disease National Collaborative Enterprise (CADENCE) announce the initiation of Asia's first cardiac gene therapy clinical trial for heart failure, with Singapore being the first and only site outside of the United States (US). …